Items where authors include "Cheeseman, S"

Article

Twelves, C, Cheeseman, S, Sopwith, W et al. (9 more authors) (2020) Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: retrospective analysis from Leeds Cancer Centre. BMC Cancer, 20 (1). 53. ISSN 1471-2407

Cheeseman, S, Thompson, M, Sopwith, W et al. (18 more authors) (2020) Current Treatment and Outcomes Benchmark for Locally Advanced or Metastatic Urothelial Cancer From a Large UK-Based Single Centre. Frontiers in Oncology, 10. 167.

Hall, PS, Lord, SR, Collinson, M et al. (12 more authors) (2017) A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO). British Journal of Cancer, 116. pp. 472-478. ISSN 0007-0920

Proceedings Paper

Twelves, C, Cheeseman, S, Thompson, M et al. (8 more authors) (2019) "Real world" characteristics, treatment patterns and outcomes of patients with hormone receptor positive (HR plus ), human epidermal growth factor 2 negative (HER2-) metastatic breast cancer (MBC). In: Cancer Research. 2018 San Antonio Breast Cancer Symposium, 04-08 Dec 2018, San Antonio, Texas, USA. American Association for Cancer Research .

Cheeseman, S, Thompson, M, Riaz, M et al. (9 more authors) (2018) Characteristics and treatment patterns in patients with locally advanced and metastatic hormone receptor positive (HR+ ), human epidermal growth factor 2 negative (HER2-) breast cancer in clinical practice: retrospective analysis from Leeds Cancer Centre. In: Value in Health. ISPOR Europe 2018, 10-14 Nov 2018, Barcelona, Spain. Elsevier , S51-S51.